REFERENCES
- Muller R. J. Med. 1981; 12: 209
- Accetto B. Am. Heart J. 1982; 103: 864
- Mauro V. F., Mauro L. S., Hageman J. H. J. Clin. Pharmacol. 1992; 32: 1054
- Beerman B., Ings R., Mansby J., Chamberlain J., McDonald A. Clin. Pharmacol. Ther. 1985; 37: 25
- Wong J. W., Yuen K. H., Peh K. K. J. Chromatogr. B: Biomed. Sci. Appl. 1998; 716: 387
- Weiner D. L. Statistics in the Pharmaceutical Industry, C. R. Buncher, J. Y. Tsay. Marcel Dekker, New York 1981; 205
- Gilbadi M., Perrier D. Pharmacokinetics. 2, Marcel Dekker, New York 1982; 145
- Wagner J. W. Fundamentals of Clinical Pharmacokinetics. 1, Drug Intelligence Publication, Hamilton, IL 1975; 285
- Grahnen A. Pharm. Int. 1984; 5: 100
- Westlake W. J. Biopharmaceutical Statistics for Drug Development, K. E. Peace. Marcel Dekker, New York 1988; 329
- U.S. Pharmacopoeial Convention. The United States Pharmacopoeia 23 Supplement 4. Rockville, MD 1995; 3223
- Steinijans V. W., Sauter R., Jonkman J. H. G., Schulz H. U., Stricker H., Blume H. Int. J. Clin. Pharmacol. Ther. Toxicol. 1989; 27: 261
- Diletti E., Haushcke D., Steinijans V. W. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29: 1